While Hydroxychloroquine alone or in combination with Azithromycin has been presented as a possible treatment modality for COVID-19, it is still considered investigational and has not been approved by the FDA. Hydroxychloroquine has been used in combination with Azithromycin for the treatment of novel COVID-19. While...

The American College of Cardiology has issued clinical guidance for cardiovascular care teams addressing the current COVID-19 pandemic. We have provided relevant points from the bulletin below. Acute Cardiac Complications of COVID-19 In a recent case report on 138 hospitalized COVID-19 patients, 16.7 percent of patients...

This February, CardioVisual was honored to be amongst six finalists in the Boston Scientific -Google Connected Patient Challenge V. We were recognized as a digital clinical navigator to empower the clinician-patient ecosystem with trusted information and digital engagement, and we had the opportunity to present...

CardioVisual is rapidly integrating with medical practices and hospital systems. Practices use our app as a validated educational tool for patients as well as to provide an ongoing educational resource to clinicians. Our aim with integration is to aid practices and clinicians in better informing...

Over at TCTMD, Asif Quasim is wondering if, in the wake of COVID-19 and the need to limit its spread, more physicians and healthcare professionals should be turning to digital solutions for their ongoing education. Medical meetings and educational summits are being canceled as alarm grows...

As the CDC warns that COVID-19 (more widely known as the novel coronavirus) will likely spread through the United States, we wish to share some information on comorbidities of COVID-19 with cardiovascular disease and diabetes. Symptoms of COVID-19 present similar to those in influenza. They include...